9 April 2017 - Not long ago Pamela Jones would have been told to get her affairs in order and sent home to die.

Instead she has a future and is looking forward to seeing her daughter graduate and retiring and travelling with her husband.

The 54-year-old is one of 223 New Zealanders who received the immunotherapy drug Keytruda in the first five months it was funded by PHARMAC.

Read New Zealand Herald article